|
× |
 |
BLUDIGO (indigotindisulfonate sodium) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SORBITAN MONOOLEATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
STEARIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
HYDROGENATED CASTOR OIL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
CHLORAPREP WITH TINT (chlorhexidine gluconate; isopropyl alcohol) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SUCRALOSE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
VOXZOGO (vosoritide) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SORBITAN Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
POLYOXYL 40 HYDROGENATED CASTOR OIL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
|